Effects of a 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Inhibitor, Fluvastatin, on Coronary Spasm After Withdrawal of Calcium-Channel Blockers
- 29 April 2008
- journal article
- clinical trial
- Published by Elsevier BV in Journal of the American College of Cardiology
- Vol. 51 (18), 1742-1748
- https://doi.org/10.1016/j.jacc.2007.12.049
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- What the Statin Trials Have Taught UsThe American Journal of Cardiology, 2006
- PLEIOTROPIC EFFECTS OF STATINSAnnual Review of Pharmacology and Toxicology, 2005
- Inflammation, Immunity, and HMG-CoA Reductase InhibitorsCirculation, 2004
- Effect of Nifedipine and Cerivastatin on Coronary Endothelial Function in Patients With Coronary Artery DiseaseCirculation, 2003
- Coronary Spasm: Clinical Features and Pathogenesis.Internal Medicine, 1997
- Coronary artery spasmCoronary Artery Disease, 1990
- Role of coronary artery spasm in symptomatic and silent myocardial ischemiaJournal of the American College of Cardiology, 1987
- Factors influencing the long-term prognosis of treated patients with variant angina.Cell Metabolism, 1983
- Treatment of variant angina with drugs: a survey of 11 cardiology institutes in Japan.Cell Metabolism, 1981
- Nifedipine Therapy for Coronary-Artery SpasmNew England Journal of Medicine, 1980